JuneBrain

Executive Summary

JuneBrain Inc. is a U.S.-based digital health company developing portable Optical Coherence Tomography (OCT) hardware and AI-driven software for remote assessment and monitoring of neurological and retinal diseases. Founded in 2018 and headquartered in Bethesda, Maryland, the company aims to expand access to advanced diagnostic care outside traditional clinical settings, such as in point-of-care environments and at-home monitoring. Its solutions integrate telehealth-enabled devices with automated analysis to support disease research, streamline clinical trials, and enhance patient monitoring. By combining hardware portability with AI interpretation, JuneBrain addresses key barriers in ophthalmology and neurology—namely, high equipment costs, limited specialist access, and the need for frequent monitoring in chronic conditions like age-related macular degeneration (AMD) and diabetic retinopathy. While the company is still in a private, pre-revenue stage with limited public information, its focus on decentralized care and AI analytics positions it well in the growing digital health market. The company's recent inclusion in industry databases suggests active development and potential near-term milestones.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for AI-based OCT analysis software75% success
• Q3 2026Strategic partnership with a major pharmaceutical company for clinical trial monitoring70% success
• Q4 2026Launch of next-generation portable OCT device60% success